Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
FEBS Letters is Scopus-indexed (Q2, CiteScore 5.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 0014-5793Verify ISSN ↗1873-3468Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: About US$3,980 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biophysics | 47 / 155 | 70th | Q2 |
| Genetics | 121 / 357 | 66th | Q2 |
| Structural Biology | 21 / 51 | 59th | Q2 |
| Biochemistry | 184 / 448 | 59th | Q2 |
| Molecular Biology | 191 / 414 | 53rd | Q2 |
| Cell Biology | 146 / 289 | 49th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1968–present, best quartile Q2, CiteScore 5.8.
FEBS Letters is Q2 in Biophysics (rank 47 of 155), Q2 in Genetics (rank 121 of 357) and Q2 in Structural Biology (rank 21 of 51), by CiteScore 2025. It is ranked in 6 subject areas in all.
FEBS Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q2 at the 70th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.181, quartile Q1, with an H-index of 295.
The publisher lists an article processing charge of about US$3,980 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
FEBS Letters is published by John Wiley and Sons Inc. Its print ISSN is 0014-5793 and its online ISSN is 1873-3468.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
FEBS Letters has an h-index of 394 and a 2-year mean of 2.89 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q2. On 2-year citations it ranks #50 of 154 Scopus journals in Biophysics.
FEBS Letters published 324 papers in 2025; its busiest recent year was 2017 with 437. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United States (14.3%), Germany (13.8%) and Japan (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 84 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.